| Stem definition | Drug id | CAS RN |
|---|---|---|
| clofibrate derivatives, peroxisome proliferator activated receptor-alpha(PPAR-alpha) agonists | 5248 | 848259-27-8 |
None
| Property | Value | Reference |
|---|---|---|
| CL (Clearance) | 4.28 mL/min/kg | Kawashima H, Watanabe R, Esaki T, Kuroda M, Nagao C, Natsume-Kitatani Y, Ohashi R, Komura H, Mizuguchi K |
| Vd (Volume of distribution) | 0.91 L/kg | Kawashima H, Watanabe R, Esaki T, Kuroda M, Nagao C, Natsume-Kitatani Y, Ohashi R, Komura H, Mizuguchi K |
| BA (Bioavailability) | 0.62 % | Kawashima H, Watanabe R, Esaki T, Kuroda M, Nagao C, Natsume-Kitatani Y, Ohashi R, Komura H, Mizuguchi K |
| Date | Agency | Company | Orphan |
|---|---|---|---|
| July 3, 2017 | PMDA | Kowa |
None
None
None
None
None
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Dyslipidemia | indication | 370992007 |
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 3.58 | acidic |
| pKa2 | 1.94 | Basic |
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Peroxisome proliferator-activated receptor alpha | Nuclear hormone receptor | AGONIST | EC50 | 9 | SCIENTIFIC LITERATURE | SCIENTIFIC LITERATURE | |||
| Peroxisome proliferator-activated receptor gamma | Nuclear hormone receptor | AGONIST | EC50 | 5.96 | SCIENTIFIC LITERATURE | ||||
| Peroxisome proliferator-activated receptor delta | Nuclear hormone receptor | AGONIST | EC50 | 5.80 | SCIENTIFIC LITERATURE |
| ID | Source |
|---|---|
| 17VGG92R23 | UNII |
| C4547051 | UMLSCUI |
| CHEMBL247951 | ChEMBL_ID |
| 11526038 | PUBCHEM_CID |
| DB15212 | DRUGBANK_ID |
| D10711 | KEGG_DRUG |
| CHEMBL3545412 | ChEMBL_ID |
| 9692 | INN_ID |
| P7F | PDB_CHEM_ID |
| C540740 | MESH_SUPPLEMENTAL_RECORD_UI |
None